Kim Branson, SVP and Global Head of AI/ML at GSK, argues that, rather than paying a penalty for holding themselves to high ethical standards, companies in fact benefit from strong ethical frameworks. Ethics-infused science, he finds, tends to generate more robust solutions and higher public trust.

Video clips from: Principled Engineering: AI and Drug Development [Entire Talk]

3 minutes

Where is AI-Driven Bioengineering Headed Next?

Watch now

9 minutes

Innovation-Driven Engagement with Regulators

Watch now

3 minutes

Ethical Science is Better Science

Watch now

3 minutes

Ethical Guardrails for AI in Drug Development

Watch now

Share Post